Figure 4.
Comparison of survival for rapamycin administered from 9 or from 20 months of age in separate yearly cohorts, pooled across sites. See text for discussion of statistical significance tests. Data for the mice exposed to rapamycin from 20 months of age are from Harrison and colleagues (2).